echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Broad-spectrum anti-tumor!

    Broad-spectrum anti-tumor!

    • Last Update: 2022-01-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    Author: Sunshine

    On December 7, CDE's official website showed that Borui Medicine's BGC0228 clinical trial application was approved by the China Food and Drug Administration for the first time for the treatment of advanced malignant solid tumors


    BGC0228 is a peptide coupling drug independently developed by Borui Medicine based on the targeted polymer coupling technology platform.


    BGC0228 replaces the antibody with a polymer target head, and forms a new compound through peptide chain combined with traditional cytotoxic drugs, which achieves precise connection without falling off, and has a smaller molecular weight than ADC drugs, so that it can smoothly penetrate tumor cells and release drugs into tumor cell tissues.


    Another class 1 new drug BGC0222 of Borui Biotechnology has entered the clinical stage.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.